Fred's Reports Second Quarter 2014 Results


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


MEMPHIS, Tenn.--(BUSINESS WIRE)--

Fred's, Inc. (NASDAQ: FRED) today reported financial results for the second quarter and six months ended August 2, 2014.

For the second quarter ended August 2, 2014, Fred's net loss totaled ($16.4) million or ($0.45) per share compared with net income of $3.3 million or $0.09 per share for the second quarter ended August 3, 2013. Fred's net loss for the first six months of fiscal 2014 was ($10.3) million or ($0.28) per share versus net income of $14.7 million or $0.40 per share in the year-earlier period.

The Company is implementing several key operational changes that will impact the results for the remainder of fiscal 2014, with positive financial returns in 2015 and beyond. These include:

  • Addressing low-productive inventory that does not fit Fred's go-forward store model.
  • The closing of 60 stores that have no pharmacies and do not meet operational performance targets.
  • Supply chain and operational improvements at stores to improve productivity and remove costs associated with excessive inventory.
  • Expanded general merchandise product sourcing capabilities.
  • The transition to a new pharmacy prime vendor agreement with Cardinal Health.

Included in the second quarter results are provisions to establish reserves for inventory clearance and store closings related to strategic changes to accelerate the implementation of Fred's convenience/pharmacy-centric store model. In total, these reserves amount to $14.8 million on a pretax basis or $0.26 per share after tax. The Company has embarked on a promotional program to reduce low-productive inventory that does not fit the convenience/pharmacy-centric model and its gross margin return-on-investment (GMROI) objectives. An $11.9 million write-down of this promotional inventory was recorded in the second quarter. In addition, the Company plans to close approximately 60 under-performing stores by the end of the fourth quarter of 2014. As a result, a write-down of the fixed assets also was recorded in the second quarter, which totaled $2.9 million.

Excluding the reserve impact, Fred's net loss in the quarter was ($7.1) million or ($0.19) per share, in line with earlier guidance.

Fred's total sales for the second quarter of fiscal 2014 increased 2% to $491.2 million from $482.2 million for the same period last year. On a comparable store basis, second quarter sales decreased 0.1% versus an increase of 2.2% for the year-earlier period. Fred's total sales for the first six months of fiscal 2014 increased 1% to $989.4 million compared with $983.7 million for the same period last year. On a comparable store basis, year-to-date sales decreased 1.0% versus an increase of 0.5% in the same period last year.

Commenting on the results, Bruce A. Efird, Chief Executive Officer, said, "Our second quarter results reflected the strategic decisions the Company has made to build our business model for the future as a convenience/pharmacy-centric store, driven by data-based inventory management and measured by GMROI. The dynamic challenges we face surfaced in the fourth quarter of 2013 throughout our general merchandise and pharmacy departments. Customer trips came under pressure from internet intrusion, while generic drug price inflation ramped up faster than payor increases were occurring. As a result, in January we undertook a deep analysis into all processes with a recognition that retail will not continue with business as usual and changes will have to take place. In the course of this evaluation, the go-forward convenience/pharmacy-centric store model emerged from the input of management, consultants, marketing teams and other market studies. Also included in this analysis was a critical view of the ongoing process of evaluating strategic alternatives, as various teams challenged and questioned the what, why, and why-not decisions in our processes.

"From this thinking came key changes that will drive the transformation of the stores to a convenience/pharmacy-centric store, which began in the second quarter:

  • An acceleration of pharmacy acquisitions that will help us achieve our target of reaching a 65% to 70% penetration rate of stores with a pharmacy, a goal that will be enhanced greatly by the recent completion of our new pharmacy distribution contract.
  • The initiation of our new marketing plan, directed at driving customer traffic through multiple avenues, including expanded ad circulars and in-store programs.
  • Data-driven inventory and category-management tools and metrics.
  • Process changes to distribution and store procedures to get our inventory directly from the truck to the store floor in the same day.
  • Expanded leadership throughout the organization, particularly in merchandising sourcing, store operations and information technology.
  • The decision to close a greater number of stores that do not fit the thresholds of the convenience/pharmacy-centric store model, allowing a reallocation of capital."

Efird added, "Although we were disappointed in second quarter financial results, there were several key wins in the quarter. We saw improvement in general merchandise sales and customer traffic from our new marketing program, which indicates positive traction for the future. The radical changes in our marketing strategy were successful in improving customer traffic, which we see as an opportunity to expand programs within the stores to show the need-it-now advantages of our model. Lastly, in pharmacy, we completed the prime vendor agreement that has substantial benefits to all aspects of our pharmacy operations and our specialty division, with components needed to support our accelerated investment in pharmacy acquisitions."

In closing, Efird said, "The investments and changes made in 2014 will bring stronger financial performance in 2015 and beyond, while allowing us to continue our growth. Our customers have already seen a difference, and the reaction is positive. Our model of stores with pharmacies continues to achieve strong operating profit and margins. Growth in pharmacy toward the 65% to 70% penetration target and improving the general merchandise financial performance remain the goals for the future success of Fred's."

Fred's gross profit for the second quarter of 2014, including the provision for inventory reserve, decreased 16% to $113.7 million from $136.0 million in the prior-year period. Gross margin for the quarter decreased to 23.1% from 28.2% in the same quarter last year. Excluding the impact of the inventory provision, gross margin was 25.6%, 260 basis points below last year. The decrease is attributable to vendor-related cost pressures on pharmacy department sales and the aggressive advertising to kick off the new marketing programs.

Gross profit for the first half of 2014, including the provision for inventory reserve, decreased to $256.1 million from $287.0 million in the prior-year period. Gross margin for the six-month period decreased to 25.9% compared with 29.2% in the prior-year period. Excluding the impact of the inventory provision, gross margin was 27.1%, 210 basis points below last year.

Selling, general and administrative expenses for the quarter, including reserves for the closing of 60 stores as well as depreciation and amortization, were 28.4% of sales compared with the prior year at 27.1% of sales in the prior-year quarter. Excluding the provision for store closures, expenses deleveraged 80 basis points to 27.9% of sales. The deleveraging is attributable to transitional costs associated with the implementation of our convenience center model and higher occupancy expenses.

In the first half of 2014, selling general and administrative expenses deleveraged 60 basis points to 27.5% from 26.9% of sales in the first half of 2013. Excluding the provision for store closures, expenses for the first half of 2014 deleveraged 30 basis points to 27.2% of sales.

For the second quarter of 2014, earnings before interest, taxes, depreciation and amortization, or EBITDA, a non-GAAP measure, decreased to a loss of ($15.9) million or (3.2%) of sales compared with $15.7 million or 3.3% of sales in the year-earlier quarter. Excluding provisions, EBITDA decreased to a loss of ($1.1) million or (0.2%) of sales.

For the first half of 2014, EBITDA decreased to $3.9 million or 0.4% of sales from $43.8 million or 4.5% of sales in the first half of 2013. Excluding reserves, EBITDA was $18.8 million or 1.9% of sales.

For the second quarter of 2014, operating income, which is equivalent to earnings before interest and taxes, or EBIT, also a non-GAAP measure, decreased to a loss of ($26.1) million or (5.3%) of sales compared with $5.2 million or 1.1% of sales in the prior-year period. Excluding provisions, operating income decreased to a loss of ($11.3) million or (2.3%) of sales.

For the first half of 2014, operating income decreased to a loss of ($16.1) million or (1.6%) of sales from $23.0 million or 2.3% of sales in the first half of 2013. Excluding reserves, operating income decreased to a loss of ($1.3) million or (0.1%) of sales.

During the second quarter, Fred's net new locations were unchanged but activity consisted of opening three new Xpress pharmacy locations and closing one full-service store and two Xpress pharmacy locations.

The Company provides the following guidance for the third quarter and full year 2014:

  • Total sales are expected to increase in the range of 3% to 5%.
  • Comparable store sales are expected to increase in the range of 1% to 3%.
  • Earnings per share on an operating basis, excluding special charges, are forecasted to be a loss in the range of $(0.05) to $(0.11).
  • EBITDA, excluding special charges, forecasted to be $6 to $9 million.
  • Based on this outlook, the Company expects earnings per diluted share on an operating basis, excluding special charges, to be approximately zero for 2014.
  • Full year 2014 EBITDA, excluding special charges, of $40 million to $46 million.

With the strategic and operational changes driven in 2014, the Company provides the following guidance for fiscal 2015:

  • Earnings per diluted share in the range of $0.72 to $0.82.
  • EBITDA in the range of $86 to $96 million.
  • Two major items driving earnings and EBITDA to the low end of these ranges are the benefits of the new pharmacy prime vendor agreement and the positive impact of the 60 stores closed in 2014. Management is confident that the other mentioned initiatives will further drive the improved results.

Currently, Fred's operates 704 discount general merchandise stores, including 21 franchised Fred's stores, in the southeastern United States. For more information about the Company, visit Fred's website at www.fredsinc.com.

A public, listen-only simulcast and replay of Fred's second quarter 2014 conference call may be accessed at the Company's web site. The simulcast will begin at approximately 5:00 p.m. Eastern Time today; a replay of the call will be available beginning at approximately 8:00 p.m. Eastern Time and will run until September 28, 2014.

Comments in this news release that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. A reader can identify forward-looking statements because they are not limited to historical facts or they use such words as "outlook," guidance," "may," "should," "could," "believe," "anticipate," "plan," "expect," "estimate," "forecast," "goal," "intend," "committed," "continue," or "will likely result" and similar expressions that concern the Company's strategy, plans, intentions or beliefs about future occurrences or results. These risks and uncertainties include, but are not limited to, those associated with the Company's announced strategic plan, the ultimate terms of the reworked pharmacy distribution agreement, lease buyouts and the underlying assumptions and projections upon which they are based, as well as risks that intended results may not be achieved or may not occur as quickly as expected; general economic trends; changes in consumer demand or purchase patterns; delays or interruptions in the flow of merchandise between the Company's distribution centers and its stores or between the Company's suppliers and same; a disruption in the Company's data processing services; costs and delays in acquiring or developing new store sites; and the factors listed under "Risk Factors" in the Company's most recent Annual Report on Form 10-K and any subsequent quarterly filings on Form 10-Q filed with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made. Fred's undertakes no obligation to release revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unforeseen events, except as required to be reported under the rules and regulations of the Securities and Exchange Commission.

 

   

 

   

 

   

 

FRED'S, INC.

Unaudited Financial Highlights

(In thousands, except per share amounts)

 

13 Weeks
Ended
August 2,
2014

13 Weeks
Ended
August 3,
2013

Percent

Change

Net sales $ 491,185 $ 482,176 1.9 %
Operating income (loss) $ (26,141 ) $ 5,213 (601.5 %)
Net income (loss) $ (16,434 ) $ 3,330 (593.5 %)
Net income (loss) per share, basic and diluted $ (0.45 ) $ 0.09 (593.5 %)
Average shares outstanding:
Basic 36,635 36,521
Diluted 36,782 36,685
 

 

26 Weeks
Ended
August 2,
2014

26 Weeks
Ended
August 3,
2013

Percent

Change

Net sales $ 989,449 $ 983,671 0.6 %
Operating income (loss) $ (16,112 ) $ 22,997 (170.1 %)
Net income (loss) $ (10,316 ) $ 14,741 (170.0 %)
Net income (loss) per share, basic and diluted $ (0.28 ) $ 0.40 (170.0 %)
Average shares outstanding:
Basic 36,611 36,525
Diluted 36,799 36,664
 

               

FRED'S, INC.

Unaudited Fiscal 2014 Second Quarter Results

(in thousands, except per share amounts)

 

13 Weeks
Ended
August 2,
2014

% of

Total

13 Weeks
Ended
August 3,
2013

% of

Total

Net sales $ 491,185 100.0 % $ 482,176 100.0 %
Cost of goods sold   377,516   76.9 %   346,191 71.8 %
Gross profit 113,669 23.1 % 135,985 28.2 %
Depreciation & amortization 10,210 2.1 % 10,527 2.2 %
Selling, general and administrative expenses   129,600   26.3 %   120,245 24.9 %
Operating income (loss) (26,141 ) (5.3 %) 5,213 1.1 %
Interest expense, net   163   0.1 %   129 0.0 %
Income (loss) before income taxes (26,304 ) (5.4 %) 5,084 1.1 %
Provision (benefit) for income taxes   (9,870 ) (2.1 %)   1,754 0.4 %
Net income (loss) $ (16,434 ) (3.3 %) $ 3,330 0.7 %

Net income (loss) per share, basic and diluted

$ (0.45 )

$

0.09

Weighted average shares outstanding:
Basic 36,635 36,521
Diluted 36,782 36,685
 

26 Weeks
Ended
August 2,
2014

% of

Total

26 Weeks
Ended
August 3,
2013

% of

Total

Net sales $ 989,449 100.0 % $ 983,671 100.0 %
Cost of goods sold   733,306   74.1 %   696,667 70.8 %
Gross profit 256,143 25.9 % 287,004 29.2 %
Depreciation & amortization 20,049 2.0 % 20,828 2.1 %
Selling, general and administrative expenses   252,206   25.5 %   243,179 24.8 %
Operating income (loss) (16,112 ) (1.6 %) 22,997 2.3 %
Interest expense, net   298   0.1 %   264 0.0 %
Income (loss) before income taxes (16,410 ) (1.7 %) 22,733 2.3 %
Provision (benefit) for income taxes   (6,094 ) (0.7 %)   7,992 0.8 %
Net income (loss) $ (10,316 ) (1.0 %) $ 14,741 1.5 %

Net income (loss) per share, basic and diluted

$ (0.28 )

$

0.40

Weighted average shares outstanding:
Basic 36,611 36,525
Diluted 36,799 36,664

 

   

 

   

 

FRED'S, INC.

Unaudited Balance Sheet

(in thousands)

 

August 2,

2014

August 3,

2013

ASSETS:
Cash and cash equivalents $ 8,088 $ 7,937
Inventories 341,976 348,324
Receivables 36,767 36,169
Other non-trade receivables 41,382 34,080
Prepaid expenses and other current assets   12,344   12,533
Total current assets 440,557 439,043
Property and equipment, net 146,294 156,720
Intangibles 65,426 42,943
Other non-current assets   11,006   3,259
Total assets $ 663,283 $ 641,965
 
LIABILITIES AND SHAREHOLDERS' EQUITY:
Accounts payable $ 121,383 $ 103,557
Current portion of indebtedness 2,024 1,148
Accrued expenses and other 46,095 46,666
Deferred income taxes   24,570   23,868
Total current liabilities 194,072 175,239
 
Long-term portion of indebtedness 15,181 4,209
Deferred income taxes - 3,656
Other non-current liabilities   15,172   15,220
Total liabilities 224,425 198,324
Shareholders' equity   438,858   443,641
Total liabilities and shareholders' equity $ 663,283 $ 641,965

Fred's, Inc.
Jerry A. Shore, 901-362-3733, Ext. 2217
Executive Vice President and
Chief Financial Officer


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Press Releases